Dr Fredrik Lehmann joins Industrifonden as Venture Partner

May 16, 2022

We are delighted to announce that Dr Fredrik Lehmann joins Industrifonden as Venture Partner bringing more than 20 years’ experience from the Life Science industry.

Fredrik Lehmann has more than 20 years of experience from the Life Science industry: as CEO and Head of Research and CMC in several companies. He has founded six companies, including OnTarget Chemistry acquired by Recipharm in 2015.

“We are excited to welcome Fredrik and proud that he has chosen to join Industrifonden. Fredrik brings extensive experience and expert know-how to our Life Science practice, one of our core investment areas. The recruitment of Fredrik is part of our effort to strengthening Industrifonden’s position as a local lead in the Nordics”, says Peter Wolpert, CEO of Industrifonden.

“I look forward to contributing to Industrifonden’s Life Science practice and innovative biotechs in particular. It is an opportunity for me to leverage my experience to support innovative Life Science ventures to reach their full potential. As an entrepreneur, I have real-life experience of the impact knowledgeable investors can have. I’m truly excited to join the team”, says Fredrik Lehmann.  

Fredrik holds a PhD in medicinal chemistry from Gothenburg University and an MBA from Stockholm School of Economics. He serves as board director at several Life Sciences companies and is a member of the Scientific Advisory Board at Akthelia Pharmaceuticals.

As Fredrik has other engagements, he will for a period work part-time at Industrifonden.

Welcome onboard Fredrik!

By continuing on the site you accept our terms and conditions for cookies. More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.